FDA-Approved Migraine Device – CEFALY
Renowned for helping prevent migraine attacks, a new FDA clearance paves way for more CEFALY devices that can now stop a migraine in progress and prevent a future episode too.
CEFALY Technology announces today the release of two new U.S. Food and Drug Administration (FDA)-cleared migraine treatment devices. CEFALY®, already the first FDA-approved external trigeminal nerve stimulation (e-TNS) device for the prevention of migraine attacks, is now the only migraine device available for use during a migraine attack with or without aura.
“We are excited that we can now offer migraine patients several drug-free options in their migraine care,” said Dr. Pierre Rigaux, the chief executive officer of CEFALY Technology, and a member of the team that invented the device. « Nous avons développé un moyen qui permet aux patients souffrant de migraine d'arrêter et de prévenir une migraine sans médicament et avec des effets secondaires quasi inexistants. »
The new FDA-approval follows several clinical trials that demonstrated that one hour of e-TNS with the CEFALYy® device can relieve or stop the migraine headache. Les résultats du traitement des migraines aiguës avec la stimulation du nerf trijumeau externe dans un essai de contrôle placebo randomisé double aveugle ont été présentés lors d'une récente réunion de l'International Headache Society. The findings showed that on average, the CEFALY® treatment reduced migraine pain by 65%. De plus, 32 % des patients n'avaient plus de douleur dans l'heure qui a suivi.
Proprietary CEFALY® technology has been adapted to efficiently and safely address the different phases of migraines. Our Connected model brings together two treatment options in a singular device as well as a bluetooth-connected integration with our CeCe app, combining treatment options with tracking tools for an all inclusive treatment plan.
Malgré ces différences, les dispositifs sont utilisés de la même façon : un dispositif est placé sur le front par une connexion magnétique à une électrode autoadhésive, qui envoie ensuite des des micro-impulsions précises à travers la peau vers les branches supérieures du nerf trijumeau, soit pour soulager les céphalées lors d'une crise migraineuse, soit pour prévenir une future crise de migraine.
Try CEFALY for 90 days, and if you are not satisfied with the product, send it back for a full refund. We'll even email you a PrePaid FedEx shipping label, so you don't have to pay for the return shipping.
Derniers messages
Le guide essentiel des dispositifs médicaux pour les migraines
CEFALY is an FDA-cleared medical device that targets the main pathway for migraine pain: the trigeminal nerve (the…
“CEFALY Gave Me My Life Back”: Camille’s Search for a Drug-Free Migraine Treatment
I've lived with migraine since my second pregnancy with my daughter. That pregnancy marked the beginning of my…
What Patients Need to Know About Episodic Migraine vs. Chronic Migraine
While official definitions classify episodic migraine as fewer than 15 headache days per month and chronic migraine as…





